Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?

Lundbeck Foundation

Status: Completed

Conditions: Postoperative Urinary Retention

Study type: Observational

Funder types: Other

Identifiers

NCT02133768

Bladder cathererisation

Lundbeck Foundation (Other Identifier)

Details and patient eligibility

About

To describe the need for re-catheterization and incidence of urological complications of routine use of perioperative fixed urinary catheter (KAD) for up to 24 hours of fast-track THA and TKA

Full description

Postoperative urinary retention (POUR) is a well known complication of fast-track total hip (THA) and knee arthroplasty (TKA), and even though medical options have been attempted, bladder catheterisation remains the only well-documented capacity to prevent and / or treat POUR.

It was previously standard to use fixed urinary catheter (KAD), the first 24-48 hours postoperatively to prevent POUR by THA and TKA, while more recent studies now recommend intermittent urinary catheterization in the postoperative period.

However, there are no detailed studies with adequate follow-up, describing the consequences of using either one or the other treatment regimen of POUR by fast-track THA and TKA.

Purpose:

To describe the need for re-catheterization and incidence of urological complications of routine use of perioperative fixed urinary catheter (KAD,catheter a demure) for up to 24 hours of fast-track THA and TKA

End Points:

1. The number of patients in need of re-catheterization due POUR
2. The number of patients in which the removal of KAD was not carried out within 24 hours.
3. The number of urinary tract infections from surgery to postoperative day (POD) 30
4. The number of patients with new-onset urinary discomfort at POD 30 (Increase in IPSS score).
5. The number of urological-related readmissions (including urosepsis) within POD 30

Enrollment: 800 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients must meet all the following criteria to be eligible to enroll in the study:

  • Age >50 years.
  • Patients scheduled for primary THA or TKA.
  • Patients who have given verbal consent to participate in the study.

Exclusion criteria

• Patients who meet one or more of the following criteria may not be included in the study:

  • Patients who can not cooperate with the study.
  • Patients who do not understand or speak Danish.
  • Patients who are permanent catheter carriers or use disposable bladder catheterisation.
  • Patients on hemodialysis.
  • Urine Derivative patients.
  • Pregnancy or childbirth within 6 months.